Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8563 |
High Similarity |
NPD7685 |
Pre-registration |
0.8333 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8274 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8256 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8225 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8187 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8121 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8118 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8107 |
Intermediate Similarity |
NPD7228 |
Approved |
0.807 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8023 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7977 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7975 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7952 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD37 |
Approved |
0.7917 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7818 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7784 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7719 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7674 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7665 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7614 |
Intermediate Similarity |
NPD7240 |
Approved |
0.759 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7574 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7543 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7514 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7439 |
Intermediate Similarity |
NPD1511 |
Approved |
0.743 |
Intermediate Similarity |
NPD8312 |
Approved |
0.743 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7429 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.736 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7353 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7341 |
Intermediate Similarity |
NPD5494 |
Approved |
0.732 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7294 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7287 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7257 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7256 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7251 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7209 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7198 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7188 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7121 |
Intermediate Similarity |
NPD7930 |
Approved |
0.712 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7105 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7101 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7078 |
Intermediate Similarity |
NPD1091 |
Approved |
0.707 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7068 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7035 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7032 |
Intermediate Similarity |
NPD1608 |
Approved |
0.703 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6989 |
Remote Similarity |
NPD919 |
Approved |
0.6988 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD5401 |
Approved |
0.6982 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6974 |
Remote Similarity |
NPD7999 |
Approved |
0.697 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.697 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.697 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6935 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6927 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD7874 |
Approved |
0.6919 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6913 |
Remote Similarity |
NPD228 |
Approved |
0.6909 |
Remote Similarity |
NPD2796 |
Approved |
0.6899 |
Remote Similarity |
NPD2797 |
Approved |
0.6894 |
Remote Similarity |
NPD3268 |
Approved |
0.6894 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6894 |
Remote Similarity |
NPD3764 |
Approved |
0.6889 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6884 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6884 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD7697 |
Approved |
0.6872 |
Remote Similarity |
NPD7698 |
Approved |
0.6872 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6871 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6871 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6855 |
Remote Similarity |
NPD2798 |
Approved |
0.6848 |
Remote Similarity |
NPD7038 |
Approved |
0.6848 |
Remote Similarity |
NPD7039 |
Approved |
0.6845 |
Remote Similarity |
NPD3750 |
Approved |
0.6842 |
Remote Similarity |
NPD6273 |
Approved |
0.6839 |
Remote Similarity |
NPD17 |
Approved |
0.6837 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6837 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6837 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6837 |
Remote Similarity |
NPD8319 |
Approved |
0.6836 |
Remote Similarity |
NPD3749 |
Approved |
0.6833 |
Remote Similarity |
NPD5242 |
Approved |
0.6832 |
Remote Similarity |
NPD7095 |
Approved |
0.6826 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6821 |
Remote Similarity |
NPD3226 |
Approved |
0.6821 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6818 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6816 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6815 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6813 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6813 |
Remote Similarity |
NPD7799 |
Discontinued |
0.681 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.681 |
Remote Similarity |
NPD1240 |
Approved |
0.6807 |
Remote Similarity |
NPD6099 |
Approved |
0.6807 |
Remote Similarity |
NPD2438 |
Suspended |
0.6807 |
Remote Similarity |
NPD6100 |
Approved |
0.6806 |
Remote Similarity |
NPD6535 |
Approved |
0.6806 |
Remote Similarity |
NPD6534 |
Approved |
0.68 |
Remote Similarity |
NPD7801 |
Approved |
0.6788 |
Remote Similarity |
NPD4420 |
Approved |
0.6784 |
Remote Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD3146 |
Approved |
0.678 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6768 |
Remote Similarity |
NPD7584 |
Approved |
0.6766 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6765 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6763 |
Remote Similarity |
NPD3686 |
Approved |
0.6763 |
Remote Similarity |
NPD3687 |
Approved |
0.6761 |
Remote Similarity |
NPD2978 |
Approved |
0.6761 |
Remote Similarity |
NPD2977 |
Approved |
0.6748 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6747
|
Remote Similarity |
NPD2799 |
Discontinued |